Loading provider…
Loading provider…
Dermatology Physician in Boston, MA
NPI: 1548227945Primary Employer
Dana-Farber Cancer Institute
dana-farber.org
HQ Phone
Get MD Thomas's Phone Numberphone_androidMobile
Get MD Thomas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 47 | 74 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 18 | 18 |
| 3 | 11104Punch biopsy of single skin lesion | 13 | 13 |
Inhibition of Melanoma Cell-Intrinsic Tim-3 Stimulates MAPK-Dependent Tumorigenesis.
Authors: Schatton, Tobias, Itoh, Yuta, Martins, Christina, Rasbach, Erik, Singh, Praveen, Silva, Mariana, Mucciarone, Kyla, Heppt, Markus V, Geddes-Sweeney, Jenna, Stewart, Kate, Brandenburg, Anne, Liang, Jennifer, Dimitroff, Charles J, Mihm, Martin C, Landsberg, Jennifer, Schlapbach, Christoph, Lian, Christine G, Murphy, George F, Kupper, Thomas S, Ramsey, Matthew R, Barthel, Steven R
Journal: Cancer Res
CCR8 is a new therapeutic target in cutaneous T-cell lymphomas.
Authors: Rachael Clark
Journal: Blood Adv
Assessing the generation of tissue resident memory T cells by vaccines.
Authors: Rotrosen, Elizabeth, Kupper, Thomas S
Journal: Nat Rev Immunol
Publication Date: 2023-03-31